Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review
Biomolecules · 07.02.2023 · 13 (2) · 315
DOI: 10.3390/biom13020315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.02.2023. Verfasst von Sunnatullo Fazliev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck School Matter to Life, Jahnstrasse 29, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Escin, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Innovation of the Republic of Uzbekistan.
Abstract (Originalsprache)
Although modern medicine is advancing at an unprecedented rate, basic challenges in cancer treatment and drug resistance remain. Exploiting natural-product-based drugs is a strategy that has been proven over time to provide diverse and efficient approaches in patient care during treatment and post-treatment periods of various diseases, including cancer. Escin—a plant-derived triterpenoid saponin—is one example of natural products with a broad therapeutic scope. Initially, escin was proven to manifest potent anti-inflammatory and anti-oedematous effects. However, in the last two decades, other novel activities of escin relevant to cancer treatment have been reported. Recent studies demonstrated escin’s efficacy in compositions with other approved drugs to accomplish synergy and increased bioavailability to broaden their apoptotic, anti-metastasis, and anti-angiogenetic effects. Here, we comprehensively discuss and present an overview of escin’s chemistry and bioavailability, and highlight its biological activities against various cancer types. We conclude the review by presenting possible future directions of research involving escin for medical and pharmaceutical applications as well as for basic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck School Matter to Life, Jahnstrasse 29, 69120 Heidelberg, Germany.
- Faculty of Engineering Sciences, Heidelberg University, Im Neuenheimer Feld 205, 69120 Heidelberg, Germany.
- Department of Inorganic, Physical and Colloidal Chemistry, Tashkent Pharmaceutical Institute, Oybek Street 45, Tashkent 100015, Uzbekistan.
- State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment, Agency for the Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan, O…
- Institute of Fundamental and Applied Research, National Research University TIIAME, Kori Niyoziy 39, Tashkent 100000, Uzbekistan.
- College of Engineering, Akfa University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan.
ORCID-Profile: Sunnatullo Fazliev, Jamoliddin Razzokov, Avez Sharipov
Förderung
- Ministry of Innovation of the Republic of Uzbekistan
Zitieren
APA
Fazliev, S., Tursunov, K., Razzokov, J., & Sharipov, A. (2023). Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review. Biomolecules, 13(2), 315. https://doi.org/10.3390/biom13020315
Vancouver
Fazliev S, Tursunov K, Razzokov J, Sharipov A. Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review. Biomolecules. 2023;13(2):315. doi:10.3390/biom13020315
BibTeX
@article{Fazliev2023,
author = {Fazliev, Sunnatullo and Tursunov, Khurshid and Razzokov, Jamoliddin and Sharipov, Avez},
title = {Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {2},
pages = {315},
doi = {10.3390/biom13020315}
}
EUVIMED